NCT01232335|Completed
Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation
ENSURE
Loading search results
ENSURE
Sponsor study identifier
observational
1,500
1 country
47
Study Start
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2013
Actual (reported)Study Completion
May 2013
Actual (reported)The purpose of this study is to confirm the safety profile for long term treatment and maximize doses and the control status on bronchial asthma in daily clinical usage
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 2013
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
October 31, 2010
Actual (reported)November 2, 2010
Actual (reported)May 2013
Actual (reported)May 2013
Actual (reported)Incidence of Adverse Events
Range of one year
The level of asthma control under long-term use
At the end of 24 weeks
The level of asthma control under long-term use
At the end of one year
Patients treated with Symbicort for the first time due to bronchial asthma
Contact the study team to confirm eligibility.
Research Site
Aichi, Japan, Japan
Research Site
Akita, Japan, Japan
Research Site
Aomori, Japan, Japan
Research Site
Chiba, Japan, Japan
Research Site
Ehime, Japan, Japan
Research Site
Fukui, Japan, Japan
Research Site
Fukuoka, Japan, Japan
Research Site
Yoshida Shigeru
AstraZeneca
1,500 participants (actual enrollment reported by the registry).
First Submitted
October 31, 2010
First Posted
November 2, 2010
Study Start
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study
Fukushima, Japan, Japan
Research Site
Gifu, Japan, Japan
Research Site
Gunma, Japan, Japan
Research Site
Hiroshima, Japan, Japan
Research Site
Hokkaido, Japan, Japan
Research Site
Hyōgo, Japan, Japan
Research Site
Ibaraki, Japan, Japan
Research Site
Ishikawa, Japan, Japan
Research Site
Kagawa, Japan, Japan
Research Site
Kagoshima, Japan, Japan
Research Site
Kanagawa, Japan, Japan
Research Site
Kochi, Japan, Japan
Research Site
Kumamoto, Japan, Japan
Research Site
Kyoto, Japan, Japan
Research Site
Mie, Japan, Japan
Research Site
Miyagi, Japan, Japan
Research Site
Miyazaki, Japan, Japan
Research Site
Nagano, Japan, Japan
Research Site
Nagasaki, Japan, Japan
Research Site
Nara, Japan, Japan
Research Site
Niigata, Japan, Japan
Research Site
Numakunai, Japan, Japan
Research Site
Okayama, Japan, Japan
Research Site
Okinawa, Japan, Japan
Research Site
Osaka, Japan, Japan
Research Site
Ōita, Japan, Japan
Research Site
Saga, Japan, Japan
Research Site
Saitama, Japan, Japan
Research Site
Shiga, Japan, Japan
Research Site
Shimane, Japan, Japan
Research Site
Shizuoka, Japan, Japan
Research Site
Tochigi, Japan, Japan
Research Site
Tokushima, Japan, Japan
Research Site
Tokyo, Japan, Japan
Research Site
Tottori, Japan, Japan
Research Site
Toyama, Japan, Japan
Research Site
Wakayama, Japan, Japan
Research Site
Yamagata, Japan, Japan
Research Site
Yamaguchi, Japan, Japan
Research Site
Yamanashi, Japan, Japan
Primary Completion
May 2013
Actual (reported)Study Completion
May 2013
Actual (reported)Last Updated
May 29, 2013
Record last verified: 2013-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: